Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Children
Risk group
Americas
Europe
Clear all
Type of publications
NITAG documentation
(11)
Systematic reviews (SYSVAC)
(1)
Topics
Available to download in languages
Regions
Americas
(7)
Europe
(5)
Africa
(1)
Western Pacific
(4)
Countries
Belgium
(1)
Bolivia
(1)
Canada
(1)
Chile
(1)
France
(1)
Ireland
(1)
Ukraine
(1)
United Kingdom
(1)
United States of America
(4)
Diseases
COVID-19
(12)
Hepatitis B
(2)
Herpes zoster
(1)
Human papillomavirus (HPV)
(1)
Influenza
(4)
Pneumococcal disease
(10)
Rotavirus
(7)
RSV (Respiratory syncytial virus)
(2)
Vaccine topics
Coverage
(1)
Target population
Children
(7)
Risk group
(5)
Adolescents
(5)
Adults
(11)
All age groups
(16)
Newborn
(2)
Parents/caregivers
(4)
Pregnant women
(9)
Travellers
(1)
Publication date
2023
(1)
2022
(3)
2021
(5)
2020
(3)
12 results found
2023
∙
NIAC
Recommendations for COVID-19 vaccination of children aged 6 months to 4 years
2022
∙
Ludvigsson, J. F. Loboda, A.
Systematic review of health and disease in Ukrainian children highlights poor child health and challenges for those treating refugees
2022
∙
NACI
Updated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration
2022
∙
Conseil Supérieur de la Santé (CSS)
Vaccination against COVID-19 with mRNA vaccines for children from 6 months of age in Belgium
2021
∙
Comité Nacional de Inmunización (CNI)
Vaccination, prevention against COVID in children under 12 years old in Bolivia
2021
∙
ACIP
COVID-19 Vaccines for Children
2021
∙
ACIP
Epidemiology of COVID-19 in Children and Teens
2021
∙
JCVI
New COVID-19 vaccine advice for adults living with adults who are immunosuppressed
2021
∙
Haute Autorité de Santé
Update of risk factors for severe forms of Covid-19 and recommendations on the strategy for prioritizing populations to be vaccinated
2020
∙
CAVEI
CAVEI provisional recommendation for the initial prioritization of groups to be vaccinated against SARS-CoV-2 in the context of limited supply
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register